This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Read about user experiences with no fee travel points cards. Gain insights to enhance your travel rewards journey!
17,260 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Jefferies positions Amazon as the leading Mag 7 stock headed into earnings, underscoring AWS momentum, Prime Day stre...
XRP punched through a key resistance level and is eyeing a higher target as bulls regain control. Here’s what’s fueli...
At a defense tech summit at the U.S. Army War College, former President Donald Trump framed geopolitics as a driver o...
Ripple's latest private-market move values the company at $50 billion and signals confidence in its ecosystem, even a...
Investors gauge SpaceX’s potential public listing amid a cautious IPO market. History from Meta’s debut suggests hype...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Ethereum recaptured a key support level and is testing the path toward $2,000. Traders are watching whether a breakou...
Bitcoin faces a pivotal test as Moody’s recession odds rise toward a historic point. Macro signals suggest crypto cou...
A Utah-based defamation suit accuses Kevin O’Leary and Fox News of tying two local political groups to the CCP amid o...
Tesla enters a pivotal period as AI-driven software and energy products meet traditional EV growth. This article asse...
A legendary friendship reveals powerful money lessons. Learn how trust, communication, and smart risk-taking can stre...